minus-Catechin-gallate-minus-Catechin-3-gallate-DataSheet-MedChemExpress_第1頁(yè)
minus-Catechin-gallate-minus-Catechin-3-gallate-DataSheet-MedChemExpress_第2頁(yè)
minus-Catechin-gallate-minus-Catechin-3-gallate-DataSheet-MedChemExpress_第3頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemE(-)-Catechin gallateCat. No.: HY-N0356CAS No.: 130405-40-2Synonyms: (-)-Catechin 3-gallate; (-)-Catechin 3-O-gallate分式: CHO分量: 442.37作靶點(diǎn): COX作通路: Immunology/Inflammation儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-

2、20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 100 mg/mL (226.06 mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 2.2606 mL 11.3028 mL 22.6055 mL5 mM 0.4521 mL 2.2606 mL 4.5211 mL10 mM 0.2261 mL 1.1303 mL 2.2606 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。體內(nèi)實(shí)驗(yàn) 請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥式選擇適當(dāng)?shù)娜芙獍?,配制前?qǐng)先配制澄清的儲(chǔ)備

3、液,再依次添加助溶劑(為保證實(shí)驗(yàn)結(jié)果的可靠性,體內(nèi)實(shí)驗(yàn)的作液,建議您現(xiàn)現(xiàn)配,當(dāng)天使;澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占):1. 請(qǐng)依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (5.65 mM); Clear solution2. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (5.65 mM); Clear solution1/2 Master o

4、f Small Molecules 您邊的抑制劑師www.MedChemEBIOLOGICAL ACTIVITY物活性 (-)-Catechin gallate綠茶茶素中的種微量組分。(-)-Catechin gallate 抑制 COX-1 和 COX-2 活性。IC50 & Target COX-1 COX-2體外研究 (-)-Catechin gallate (CG) directly interacts with DNA oligomers and inhibits the activity of COX-1 and COX-2enzymes, the gene expression

5、of matrix metalloproteinase-9 in macrophage-differentiated HL-60 myeloidleukemia cells, the adipocyte uptake of glucose by the transporter, GLUT4, and the activities of variousproteasomes, i.e., the multicatalytic proteases responsible for the degradation of most cellular proteins. Therelative cytot

6、oxicities of a 3-day exposure to (-)-Catechin gallate are determined for cancerous CAL27 andHSG cells, immortalized epithelioid S-G cells, and normal HGF-1 gingival fibroblasts. The concentration atwhich toxicity (P0.01) initially occur is 25 M (-)-Catechin gallate for S-G cells, 50 M (-)-Catechin g

7、allate forCAL27 cells, 62.5 M (-)-Catechin gallate for HSG cells and 75 M (-)-Catechin gallate for HGF-1 fibroblasts.The calculated neutral red (NR50) values for a 3-day exposure to (-)-Catechin gallate are 58 M for S-Gcells, 62 M for CAL27 cells, 90 M for HSG cells and 132 M for HGF-1 fibroblasts 1

8、.PROTOCOLCell Assay 1 Human tongue squamous carcinoma (CAL27) cells and human salivary gland carcinoma (HSG) cells areused. Individual wells of a 96-well microtiter tissue culture plate are inoculated with 0.2 mL of the growthmedium containing 2104 cells/well for a 1-day exposure, 1.5104 cells/ well

9、 for a 2-day exposure and1104 cells/well for a 3-day exposure to the test agents. After 1 day of incubation, the growth medium isremoved and replaced with exposure medium, with or without varied concentrations of the test agents. Insome studies the cells are coexposed to (-)-Catechin gallate (100, 2

10、00, 300, 400, and 500 M) and 100Units/mL catalase. After 1-3 days of exposure to the test agents, viability is assessed with the neutral red(NR) assay, which is based on the uptake and accumulation of the supravital dye, neutral red (NR) 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Babich H, et al. In vitro cytotoxicity of (-)-catechin gallate, a minor polyphenol in green tea. Toxicol Lett. 2007 Jul 10;171(3):171-80.McePdfHeightCaution: Product has not been f

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論